This document discusses hypoglycemia in infants of diabetic mothers. It begins by outlining the risks of hypoglycemia in these infants, including transient drops in blood glucose levels after birth due to high insulin levels. It then discusses the causes, symptoms, diagnosis and management of hypoglycemia. Key points include the importance of monitoring blood glucose levels, treating low levels aggressively with IV dextrose boluses and infusions, and addressing any other issues such as hypocalcemia.
Best Rate (Hyderabad) Call Girls Jahanuma ⟟ 8250192130 ⟟ High Class Call Girl...
Neonatal Hypoglycemia and Infant of a Diabetic Mother
1. Hypoglycemia, Infant of a
Diabetic Mother
Dr. Kalpana Malla
MD Pediatrics
Manipal Teaching Hospital
Download more documents and slide shows on The Medical Post [ www.themedicalpost.net ]
2. Preparation for Birth
• Newborn’s blood glucose 60-70 % of
maternal level falls during first 24 hrs
(lowest at 3 hrs)transient rise during next
24 hrs falls again at 3-4 days stable
Karlsen, 2006
3. What is Normal?
• Defining a normal glucose level remains
controversial
– 50 – 110 mg/dl (Karlsen, 2006)
– > 40 mg/dl (Verklan & Walden, 2004)
– > 30 term, > 20 preterm (Kenner & Lott, 2004)
– > 45 mg/dl (Cowett, R. as cited by Barnes-Powell, 2007)
4. Incidence of Hypoglycemia
• Incidence = 1- 5/1000 live births
– Normal newborns – 10% if feeding is delayed for
3-6 hours after birth
– At-Risk Infants – 30%
• LGA – 8%
• Preterm – 15%
• SGA – 15%
• IDM – 20%
McGowan, 1999 as cited by
Verklan & Walden
5. Hypoglycemia
Definition:
Blood glucose < 40mg/dl (< 2.2 mmol / L)
at any time regardless of gestational age
**Normal glucose level 30-60mg/dl (1.7-
3.3mmol/L)
** Target 1st D >40 mg/dl
> 40-50 mg/dl thereafter
13. SYMPTOMS
• Asymptomatic
• Lethargy, apathy and limpness
• Apnea
• Cyanosis
• Weak or high pitched cry
• Seizures, coma
• Poor feeding, vomiting
• Tremors, jitteriness or irritability
14. DIAGNOSIS
• Reagent strips – Glucostix
- Confirmatory lab test is required
- Serial measurements for those having
symptoms
• Hypoglycemia lasting > a week
require endocrine work up -insulin,
GH, cortisol, ACTH, T4, glucagon,
amino acids and urine for ketones,
reducing substance, amino acids and
organic acids
15. MANAGEMENT
• Well neonates who are at risk –
Monitor/ feed
• Symptomatic- IV 10% dextose 2-
5ml/kg. Follow this by infusion
8mg/kg/min recheck after 30 min and
hourly until stable. Increase infusion as
required.
• Other therapy- Hydrocortisone,
glucagon, Epinephrine, diazoxide and
growth hormone
17. Infants of Diabetic Mothers
**Babies born to diabetic or gestational
diabetic mothers
• 1st trimester------diabetic embryopathy
• Last trimester---------macrosomia
• Birth weight > 4000 g - 90th percentile GA
18. Introduction:
• Gestational diabetes (GDM): defined as
carbohydrate intolerance of variable severity first
diagnosed during pregnancy
• Affects 3 % of all pregnancies
• Risk factors for GDM:
- advanced maternal age
- multifetal gestation
- increased BMI
- family h/o DM
20. Maternal Hyperglycemia
• Dose and time dependent
• Post implantation rat embryo 100% teratogenic
dose 950 mg/dl D-glucose
Day 10 primary neural tube defect
Day 11 cardiac defects
Day 12 no defects
21. Fetal Hyperglycemia
• 1-2 hours of fetal hyperglycemia can have
detrimental effects
• insulin secretion
– Storage of excess nutrients macrosomia
– Post natal hypoglycemia
22. IDM – Effects on Fetus
• Glucose crosses the placenta
• Insulin does not cross the placenta
• Results – fetus produces own insulin in the presence
of elevated glucose from the mother
23. IDM – Risks > general population
• Birth injury is doubled
• C/S is tripled
• NICU admission is quadrupled
• Stillbirth is x 5 greater
• Congenital anomalies are x 2 – 5 greater
24. Congenital Malformations
• Overall incidence---5 to 9%
– 2-3 fold higher than general population
– Predominantly with IDDM
• Malformations of CNS seen most often
• Diversity-No malformation considered
pathognomonic
25. Congenital Malformations
• No increase in major congenital
malformations among offspring of
– Diabetic fathers
– Prediabetic women
– GDM after first trimester
27. Caudal Regression Syndrome
• Spectrum of malformation
– cessation of growth of rostral
portion of spinal cord
– abnormal neural, muscular, skeletal
and vascular components
Caudal Regression with limbs
intact but malformed
Sirenomelia
Absence of hind limbs, external
genitalia, anus and rectum; Potter
sequence secondary renal agenesis
37. Problems
• Natal :
• Fetal macrosomia-difficult delivery,
birth injury - Erb’s palsy, Clavicle
fracture, Phrenic N palsy
• Sudden unexpected fetal death –
ketoacidosis
• Usually LSCS
• Large placenta
• Premature delivery
• TTN
38. Problems (post natal)
• Hypoglycemia- within 1-3 hrs of birth
IDM -75% get in 1st 24 hr
GDM -25% get in 1st 24 hr
• Hypocalcemia 24-72 hrs of birth(50%)
• Polycythemia
• Hyperbilirubinemia
39. Problems (post natal)
• Respiratory distress – HMD Large
baby( LFD)
• Delayed passage of meconium delayed
devl of left colon
• Hypomagnesemia –related with
maternal hypomagnesemia with DM
40. Associated Cong anomalies
• 3-4 times more common
• Hyperglycemia induced teratogenicity
1. CNS- neural tube defects-
Anencephaly, holoporencephaly,
meningocele
2. Vertebral –caudal regression syndrome –
lumbo sacral agenesis
3.Renal – R. vein thrombosis, renal
agenesis hydronephrosis
41. 4.Cardiac
• 5 times more
common—
• Transient
hypertrophic
subaortic stenosis
• Septal hypertrophy,
• Hypertrophic
cardiomyopathy
• CCF
42. Associated Cong anomalies
4. Cardiac….. – VSD, ASD, Co.Aorta,
TGA
5.Gastrointestinal - Small left colon
syndrome-abdominal distension,
Duodenal or anorectal atresia
46. On examination
• Polycythemia— if PCV>65%
• signs of hyperviscosity —jitteriness,
tachypnoea, cyanosis ,seizures, poor
feeding. At times RV thrombosis,
hyperbilirubinemia
47. DIAGNOSIS
Babies at high risk should be screened within the first
1-2 hours
- reagent strips-measure whole blood glucose-15% lower
than plasma levels
- Confirmatory blood sugar determination is required-
and the blood should taken to the lab immediately
since glucose levels can fall 18 mg/dl/hour in the
blood sample that awaits analysis
- Septic screen
48. Monitoring in IDM:
• Check blood glucose level at 1,2,3,6,12,24,26
and 48 hrs
• Hematocrit at 1 and 24 hrs
• Calcium levels if baby appears jittery or sick
• Bilirubin if clinically jaundiced
49. Investigations
• C BC-hct
• Blood sugar-1st hr of birth ,then
2,3,6,8,12,24,48th hrs of birth
• S.calcium, S. magnesium
• CXR – Cardiomegaly 30% HF-
10% Features of HMD
• USG-renal, gut anomalies
• ECHO
50. Management: mother
• 1. Proper control of maternal DM-
- No Oral Hypoglycemics- due to
teratogencity/intractable hypoglyce
- Insulin to keep BSL<120mg
• Assessment of fetal maturity—signs of
lung maturity—L:S ratio >3.5
(normally>2)
• Elective LSCS
51. Treatment
• Asymptomatic- breast feeds/formula- repeat
blood test in one hour- if glucose does not
come up-aggressive therapy is required
• IV therapy-indications
- Symptomatic
- Inability to tolerate oral feeds
- Glucose level < 25 mg%
- oral feedings do not maintain glucose levels
52. IV Dextrose:
• 2 ml/kg of 10%dextrose
• For symptomatic hypoglycemia- 10 %
dextrose 4 ml/kg
• Continuing treatment- 6-8mg/kg/min
• Recheck 20-30 min and hourly until stable
• Additional bolus infusion-2 ml/kg of 10%
dextrose
• If glucose is stable-feeding reintroduced
and glucose infusion tapered
53. continued
• Increase glucose infusion upto 12-15 mg/kg/min
• In these cases-hydrocortisone 10 mg/kg/day may be
used
• Glucagon (25-300 micrograms) -may be used in
neonates with good glycogen stores- temporary
measure-until IV access is available
• Other drugs- diazoxide/verapamil-refer to a tertiary
centre
54. hypoglycemia
10 % dextrose 2 ml/kg
glucose infusion 6 mg/kg/min
gRBS 20-30 min
still low
10 % dextrose 2 ml/kg
glucose infusion 8 mg/kg/min
gRBS still low
hydrocortisone 10 mg/kg/d
gRBS still low
glucagon IM (0.025-0.3 mg/kg)
diazoxide 2-5 mg/kg q8hr PO
epinephrine/ GH subtotal pancreatectomy
56. Management: baby
3.Symptomatic & hypoglycemia
If symptoms – 4ml /kg 10% glucose IV
followed by 10% glucose drip 8mg (.08ml
/kg / m for 2 days - monitor BSL 2 hrly
until >40mg/dl ,then monitor 4-6 hrly
– Then gradually decrease rate if stable
for 24-48 hrs
57. If recurs
• Hypertonic glucose 12-20%
IV hydrocortisone
oral prednisolone
IM GH
• If hyperinsulinemic hypoglycemia
oral diazoxide
oral octretide
58. Management: baby
• Treat complications
• Treat infections
• If severe polycythaemia—partial ET
with plasma/saline
74. Treatment protocol
• Correction of acidosis by bicarbonate
is required only if pH < 7
• When blood glucose –normal give S/c
insulin and stop insulin drip 30 min
after this
75. Treatment protocol
• 0.5-0.7units/kg (IA) insulin + 0.1 units/kg
regular insulin SC at 4-6hrly
• Adjust dose daily until satisfactory
glycemic control is achieved
• Injection site – rotated to avoid
lipohypertrophy
• Posterior .upper extremity, anterior
thigh, buttocks, anterior abdominal wall
76. Long-term complications
Diabetic retinopathy
– Within 5 years of onset of diabetes.
– 80% with IDDM develop retinopathy.
Diabetic nephropathy
– Peak incidence is in post adolescents, 10-15
years after diagnosis
– 30% with IDDM.
78. Follow up
– Growth assessment
– Injection site examination
– Retinoscopy or other retinal screening
– Blood pressure
79. Follow up
– Examination of hands, feet, and peripheral
pulses, signs of limited joint mobility,
peripheral neuropathy, and vascular disease
– Evaluation for signs of associated
autoimmune disease
– Urine examination for microalbuminuria
81. Phases of diabetes
• Development of clinical symptoms
• Honeymoon phase
• Relapse
• Total diabetes - irreversible
82. Honeymoon period
• Phase of remission after initial
stabilization
• Due to residual β-cell function –residual
insulin secretion
• 75% go into this phase
• 5% go into complete remission
• Phase – variable ( wks/months /1-2 yrs)
83. Somogyi phenomenon
• Hypoglycemic episode followed by rapid
onset of hyperglecemia
• Due to counter regulatory hormones in
response to insulin induced
hypoglycemia
• Also described as hypoglycemia
begetting hyperglycemia
84. Dawn phenomenon
• Hyperglycemia at 5-9 am without
preceeding hypoglycemia
• Due to Waning effects of biologically
available insulin & nocturnal surges of GH
• Normal event
85. Distinguish ( Somogyi& Dawm P)
• Blood glucose at 3,4,7 am
• Dawn P - >80mg/dl in 1st sample (3am)
and markedly higher in last sample &
am-↑ evening dose or delay evening
dose by 2-3 hrs
• Somogyi P – ≤ 60mg/dl in 1st
sample(3am) –rebound hyperglycemia at
7 am -↓ evening dose or delay insulin at
9 pm
86. Brittle diabetes
• Control of blood glucose fluctuates
widely & rapidly despite frequent
adjustment of dose of insulin
• Somogyi & dawn phenomenon – most
common causes
87. Thank you
Download more documents and slide shows on The
Medical Post [ www.themedicalpost.net ]